Influence of Two Variants of CYP450 Oxidoreductase on the Stable Dose of Acenocoumarol in a Spanish Population

References

• Miller WL . Minireview: regulation of steroidogenesis by electron transfer . Endocrinology146 ( 6 ), 2544 – 2550 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Miller W , HuangN , AgrawalV , GiacominiK . Genetic variation in human P450 oxidoreductase . Mol. Cell. Endocrinol.300 , 180 – 184 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Huang N , AgrawalV , GiacominiK , MillerW . Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations . Proc. Natl Acad. Sci. USA105 ( 5 ), 1733 – 1738 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hart SN , WangS , NakamotoK , WesselmanC , LiY , ZhongXB . Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism . Pharmacogenet. Genomics18 ( 1 ), 11 – 24 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Agrawal V , ChoiJH , GiacominiKM , MillerWL . Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase . Pharmacogenet. Genomics20 ( 10 ), 611 – 618 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lesche D , SigurdardottirV , SetoudRet al. CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients . Ther. Drug Monit.36 ( 6 ), 710 – 715 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jannot AS , VuilleminX , EtienneIet al. A lack of significant effect of POR*28 allelic variant on tacrolimus exposure in kidney transplant recipients . Ther. Drug Monit.38 ( 2 ), 223 – 229 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Subramanian M , AgrawalV , SandeeD , TamHK , MillerWL , TracyTS . Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3 . Pharmacogenet. Genomics22 ( 8 ), 590 – 597 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ragia G , TavridouA , ElensL , Van SchaikRH , ManolopoulosVG . CYP2C9*2 allele increases risk for hypoglycemia in POR*1/*1 Type 2 diabetic patients treated with sulfonylureas . Exp. Clin. Endocrinol. Diabetes122 ( 1 ), 60 – 63 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhang X , LiL , DingX , KaminskyLS . Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose . Drug Metab. Dispos.39 ( 8 ), 1433 – 1439 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Tan SL , LiZ , ZhangWet al. Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han–Chinese patients with mechanical heart valve replacement . Eur. J. Clin. Pharmacol.69 ( 10 ), 1769 – 1775 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Borobia AM , LubomirovR , RamirezEet al. An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease . PLoS ONE7 ( 7 ), e41360 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tong HY , Dávila-FajardoCL , BorobiaAMet al. A new pharmacogenetic algorithm to predict the most appropriate dosage of acenocoumarol for stable anticoagulation in a mixed Spanish population . PLoS ONE 15 , 11 ( 3 ), e0150456 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Akaike H . A new look at the statistical model identification . IEEE Trans. Automat. Contr.19 ( 6 ), 716 – 723 ( 1974 ).
   Web of Science ®Google Scholar
• R Core Team . A language and environment for statistical computing; R Foundation for Statistical Computing, Vienna, Austria ( 2013 ).
   Google Scholar
• RStudio Team . RStudio: Integrated Development for R. RStudio ( 2015 ).
   Google Scholar
• NCIB . dbSNP short genetic variations: Reference SNP (refSNP) cluster report: rs286817 . www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2868177 .
   Google Scholar
• Rianne MF , van SchieRM , WesselsJAet al. Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data . Eur. Heart J.32 ( 15 ), 1909 – 1917 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Cerezo–Manchado JJ , RosafalcoM , AntónAIet al. Creating a genotype-based dosing algorithm for acenocoumarol steady dose . Thromb. Haemost.109 ( 1 ), 146 – 153 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Verhoef TI , RagiaG , de BoerAet al. A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon . N. Engl. J. Med.369 ( 24 ), 2304 – 2312 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pirmohamed M , BurnsideG , ErikssonNet al. A randomized trial of genotype-guided dosing of warfarin . N. Engl. J. Med.369 ( 24 ), 2294 – 2303 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• de Jonge H , MetalidisC , NaesensM , LambrechtsD , KuypersDR . The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients . Pharmacogenomics12 ( 9 ), 1281 – 1291 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Elens L , NieuweboerAJ , ClarkeSJet al. Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin . Pharmacogenet. Genomics23 ( 3 ), 148 – 155 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ragia G , KolovouV , TavridouAet al. Lack of association of the p450 oxidoreductase *28 single nucleotide polymorphism with the lipid-lowering effect of statins in hypercholesterolemic patients . Mol. Diagn. Ther.18 ( 3 ), 323 – 331 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Friedman J , TibshiraniR , HastieT . The Elements of Statistical Learning . Springer , NY, USA ( 2009 ).
   Google Scholar